Jason Avery

Fjord Marin AS provides ship brokerage services. The company was founded in 1994 and is headquartered in Måløy, Norway.

Verdane Capital Advisors AS (Verdane Capital Advisors) is a private equity firm founded in 1985 by Birger Nergaard. The firm is headquartered in Oslo with additional offices in Berlin, Copenhagen, Helsinki, London, Munich and Stockholm.

TeamTec AS manufactures marine incinerators and stripping ejector equipment. Its products include AVITALIS™ BWTS, Incinerators, Ejectors, Machining & Casting, and Fire-Rated Windows. The company was founded in 1984 and is headquartered in Tvedestrand, Norway.

Holmen Industri Invest 1 AS is a Norwegian investment company. The private company is based in Oslo, Norway. The CEO of the company is Karl-Erik Staubo.

ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK.

Aqua Gen AS produces and distributes fertilized eggs of Atlantic salmon and rainbow trout. It is a selective breeding firm which develops, produces and delivers genetic material to the global sea-farming industry. The firm's products include salmon eggs and rainbow trout eggs. The company was founded in 1992 and it is headquartered in Trondheim, Norway.

TeamTec Invest AS operates as a holding company with interests in manufacturing of marine equipment. The company was founded in 2005 and is headquartered in Tvedestrand, Norway.

Industriverktøy AS manufactures precision plastic mouldings. The company is headquartered in Leksvik, Norway.

The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012.

Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway.

Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway.

Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland.

Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway.

AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark.

APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway.

ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark.

Scanbio Marine Group AS engages in the production of animal feed ingredients from fish by-products. It offers fish oil and fishmeal from preserved by-products (silage) and fresh raw materials. The company was founded in 1909 and is headquartered in Trondheim, Norway.

Actigen Ltd. provides biological products. The private company is based in Cambridge, UK.

BioXpress Therapeutics SA provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity. The company is headquartered in Plan-les-Ouates, Switzerland.

Zelluna Immunotherapy AS engages in research and development on biotechnology. The company is headquartered in Oslo, Norway.

Part of AstraZeneca PLC, Cambridge Antibody Technology Group Ltd. is a holding company that oversees its subsidiaries' research, development, and exploitation of molecular engineering products. The company is based in Cambridge, UK and was founded in 1996.

Apollo Therapeutics LLP is a British biopharmaceutical company that focuses on translating medical research into medicines. The company is based in Stevenage, UK. The company has a portfolio-model built around a centralized management team of experts in pharmaceutical R&D, manufacturing, commercial strategy, fundraising, and business development. The company's assets are housed in separate wholly-owned subsidiary companies, which incorporate best practices from big pharma and venture capital. The company has a scalable R&D platform for the discovery and development of new medicines, enabled by access to five of the world's leading universities and research institutes. The company was founded in 2015, and the CEO is Richard Mason.

Apollo Therapeutics Group Ltd. is an investment holding British company. The private company is based in Cambridge, UK. The company was founded in 2021. The CEO is Richard Mason.